Shafigh Navid, Roodneshin Fatemeh, Hasheminik Morteza, Shafigh Elnaz, Shahrabadi Hosein, Niknezhad Jalali Arezou, Gharehbeglou Mohammad, Alipour Hale, Ordoni Avval Jamshid, Hashemian Seyed Mohammad Reza
Department of Anesthesiology and Critical Care Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Department of Nursing, Sabzevar Branch, Islamic Azad University, Sabzevar, Iran.
Tanaffos. 2024 Jan;23(1):93-96.
Coagulation disorder is common among COVID-19 patients, particularly those afflicted with the severe form of the disease. Manifestations of thrombotic complications such as pulmonary embolism, deep vein thrombosis (DVT), ischemic stroke, cardiac infarction and arterial embolism is high in COVID-19 patients which have been assessed in various studies (5).It seems that COVID-19-related coagulopathy is a combination of low-grade DIC and pulmonary thrombotic microangiopathy which can have a significant effect on organ dysfunction in patients with severe COVID-19 (6). Numerous complications have been reported following COVID-19 disease. Although the disease often improves after going through various clinical phases, some people have short-term or long-term complications including coagulationdisorders. This case report presents an unusual instance of extensive left ventricular thrombosis in a patient who had recently recovered from COVID-19, despite being on anticoagulant prophylaxis.
凝血功能障碍在新冠肺炎患者中很常见,尤其是那些患有重症的患者。在多项研究中评估发现,新冠肺炎患者出现血栓形成并发症(如肺栓塞、深静脉血栓形成(DVT)、缺血性中风、心肌梗死和动脉栓塞)的表现很常见(5)。似乎新冠肺炎相关凝血病是轻度弥散性血管内凝血(DIC)和肺血栓性微血管病的组合,这可能对重症新冠肺炎患者的器官功能障碍产生重大影响(6)。新冠肺炎疾病后报告了许多并发症。尽管该疾病在经历不同临床阶段后通常会好转,但有些人会出现短期或长期并发症包括凝血功能障碍。本病例报告展示了一名近期从新冠肺炎康复的患者,尽管接受了抗凝预防,但仍出现广泛左心室血栓形成的罕见病例。